Literature DB >> 97703

A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.

A S Bloom, W L Dewey.   

Abstract

The effects of morphine and delta9-tetrahydrocannabinol(THC)on the tail-flick reflex, body temperature, and catecholamine synthesis were examined in the mouse in order to compare their effects in a single species and strain under uniform conditions. Naloxone antagonism of THC and cross-tolerance between morphine and THC were also studied. Both morphine and THC produced antinociception, hypothermia, and increased catecholamine synthesis at 30 min after s.c. injection. Morphine produced greater increases in dopamine synthesis and was a more potent antinociceptive agent, while THC produced greater increases in norepinephrine synthesis and was a more potent hypothermic agent. Naloxone pretreatment (1 mg/kg) partially antagonized the hypothermia and increase in catecholamine synthesis produced by THC. There was also cross-tolerance between morphine and THC, but it was asymmetric in that THC-tolerant animals were cross-tolerant to only the hypothermic action of morphine and morphine-tolerant animals cross-tolerant to only the antinociceptive action of THC.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97703     DOI: 10.1007/bf00426745

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.

Authors:  B Hine; E Friedman; M Torrelio; S Gershon
Journal:  Science       Date:  1975-02-07       Impact factor: 47.728

2.  A NEW CONCEPT OF TEMPERATURE REGULATION BY AMINES IN THE HYPOTHALAMUS.

Authors:  W FELDBERG; R D MYERS
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

3.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

4.  The correlation between antinociceptive activity of narcotics and their antagonists as measured in the mouse tail-flick test and increased synthesis of brain catecholamines.

Authors:  A S Bloom; W L Dewey; L S Harris; K K Brosius
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

5.  Evidence that methadone blocks dopamine receptors in the brain.

Authors:  H A Sasame; J Perez-Cruet; G Di Chiara; A Tagliamonte; P Tagliamonte; G L Gessa
Journal:  J Neurochem       Date:  1972-08       Impact factor: 5.372

6.  Pharmacology of some marijuana constituents and 2 heterocyclic analogues.

Authors:  W L Dewey; L S Harris; J F Howes; J S Kennedy; F E Granchelli; H G Pars; R K Razdan
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

7.  Daily rhythm in the accumulation of brain catechol-amines synthesized fom circulating H3-tyrosine.

Authors:  M J Zigmond; R J Wurtman
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

8.  An intravenous formulation of 9-tetrahydrocannabinol using a non-ionic surfactant.

Authors:  J C Cradock; J P Davignon; C L Litterst; A M Guarino
Journal:  J Pharm Pharmacol       Date:  1973-04       Impact factor: 3.765

9.  Role of catecholamines in the hypothermic activity of cannabis in albino rats.

Authors:  P P Singh; P K Das
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

10.  Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.

Authors:  H N Bhargava
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

View more
  17 in total

1.  Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Christian A Kell; Ulrike Nöth; Johannes Vermehren; Jochen Kaiser; Ralf Deichmann; Jörn Lötsch
Journal:  Neuropsychopharmacology       Date:  2015-10-30       Impact factor: 7.853

2.  Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L.

Authors:  S Ferri; E Cavicchini; P Romualdi; E Speroni; G Murari
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  The effects of Δ9-tetrahydrocannabinol on the dopamine system.

Authors:  Michael A P Bloomfield; Abhishekh H Ashok; Nora D Volkow; Oliver D Howes
Journal:  Nature       Date:  2016-11-17       Impact factor: 49.962

4.  Effect of acute administration of delta 1-tetrahydrocannabinol on beta-endorphin levels in plasma and brain tissue of the rat.

Authors:  V M Wiegant; C G Sweep; I Nir
Journal:  Experientia       Date:  1987-04-15

5.  Interaction of ambient temperature with the effects of delta 9-tetrahydrocannabinol on brain catecholamine synthesis and plasma corticosterone levels.

Authors:  A S Bloom; C J Kiernan
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 6.  Signal transduction via cannabinoid receptors.

Authors:  George D Dalton; Caroline E Bass; C G Van Horn; Allyn C Howlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

7.  The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.

Authors:  Zuzana Justinova; Gianluigi Tanda; Patrik Munzar; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

Review 8.  Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.

Authors:  Bjorn Jensen; Jeffrey Chen; Tim Furnish; Mark Wallace
Journal:  Curr Pain Headache Rep       Date:  2015-10

9.  Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors.

Authors:  A Zani; D Braida; V Capurro; M Sala
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 10.  Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.

Authors:  Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2016-03-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.